Carmignac Portfolio Grande Europe F EUR AccRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 20.9 | 14.9 | -16.1 | 12.8 | 9.8 | |
+/-Cat | 6.3 | -1.9 | -0.1 | -0.6 | 2.8 | |
+/-B’mrk | 9.0 | -5.2 | -3.1 | -0.6 | 1.1 | |
Category: Europe Large-Cap Growth Equity | ||||||
Category Benchmark: MSCI Europe Growth NR EUR |
Key Stats | ||
NAV 25/04/2024 | EUR 220.50 | |
Day Change | -1.59% | |
Morningstar Category™ | Europe Large-Cap Growth Equity | |
ISIN | LU0992628858 | |
Fund Size (Mil) 25/04/2024 | EUR 855.12 | |
Share Class Size (Mil) 25/04/2024 | EUR 309.42 | |
Max Initial Charge | - | |
Ongoing Charge 19/02/2024 | 1.15% |
Investment Objective: Carmignac Portfolio Grande Europe F EUR Acc |
The Sub-Fund‘s objective is to outperform its reference indicator over a recommended investment horizon of five years. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Mark Denham 02/03/2018 | ||
Inception Date 15/11/2013 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
STOXX Europe 600 NR EUR | MSCI Europe Growth NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Carmignac Portfolio Grande Europe F EUR Acc | 31/03/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 9.23 |
SAP SE | Technology | 8.22 |
ASML Holding NV | Technology | 7.31 |
L'Oreal SA | Consumer Defensive | 6.62 |
Lonza Group Ltd | Healthcare | 5.33 |
Increase Decrease New since last portfolio | ||
Carmignac Portfolio Grande Europe F EUR Acc |